Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Eldon Biologicals is a private Danish healthcare company that manufactures dry-format point-of-care blood grouping cards marketed as EldonCard. The company focuses on rapid ABO and RhD blood typing for use in hospitals, blood banks, emergency and field settings, and consumer home testing. Its cards use dried formulations of selected monoclonal antibodies and are designed to deliver results in about two minutes without refrigeration or blood component separation. The company states that EldonCards have been used for more than 40 years, are CE marked in Europe, and are cleared by the U.S. FDA. Eldon Biologicals appears to be a commercial-stage diagnostics and medical device business rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Eldon Biologicals.